ORION Corp. (KRX:271560)
South Korea · Delayed Price · Currency is KRW | Market Cap | 5.38T +14.2% |
| Revenue (ttm) | 3.33T +7.3% |
| Net Income | 382.71B -27.0% |
| EPS | 9,681.68 -27.0% |
| Shares Out | 39.53M |
| PE Ratio | 14.07 |
| Forward PE | 11.05 |
| Dividend | 2,500.00 (1.81%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 101,238 |
| Average Volume | 100,511 |
| Open | 137,000 |
| Previous Close | 136,200 |
| Day's Range | 133,450 - 137,400 |
| 52-Week Range | 99,000 - 150,100 |
| Beta | 0.36 |
| RSI | 45.26 |
| Earnings Date | May 21, 2026 |
About ORION
ORION Corp. engages in the confectionery business worldwide. It offers pies, snacks, biscuits, candies and jellies, gums, and chocolates under the Orion Power brand; whole wheat biscuits, bars, and drinks under the Dr.You brand; and brownies, crackers, cheese chips, and chocolate products under the Market O brand; desserts under the Chocopie House brand name; and mineral water under the Jeju yongamsoo brand. The company also produce and distributes films; and owns and operates a basketball team. The company was formerly known as Tongyang Confec... [Read more]
Financial Performance
In 2025, ORION's revenue was 3.33 trillion, an increase of 7.35% compared to the previous year's 3.10 trillion. Earnings were 382.71 billion, a decrease of -27.05%.
Financial StatementsNews
Orion Corporation's financial reporting and Annual General Meeting in 2026
ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 18 JULY 2025 at 9.30 EEST Orion Corporation's financial reporting and Annual General Meeting in 2026 Orion Corporation will publish its Fi...
Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe
Shilpa Medicare Limited has announced that its wholly owned subsidiary, Shilpa Biocare Private Limited, has entered into a strategic agreement with Orion Corporation, a pharmaceutical company based in...